Lemaitre Vascular (LMAT) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
LeMaitre Vascular (LMAT) PT Raised to $29 at Stifel; Reiterates Buy
April 27, 2017 8:45 AM EDTStifel raised its price target on LeMaitre Vascular (NASDAQ: LMAT) to $29.00 (from $25.00) while maintaining a Buy rating. EPS of $0.16 grew 40%+ Y/Y. A lower than projected 1Q tax rate added $0.01-0.02 of EPS. But even excluding this benefit, the results still would have exceeded EPS... More
